Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 4Gastro-enteropancreatic neuroendocrine tumor 4Carcinoma, Hepatocellular 2Carcinoid Tumor 2Pancreatic Neoplasms 1Neoplastic Cells, Circulating 1Gastrointestinal Neoplasms 1Adenoma, Islet Cell 1Acromegaly 1

Interventions

Blood Specimen Collection 4Reverse Transcriptase Polymerase Chain Reaction 3Flow Cytometry 3Surgical Procedures, Operative 2Propofol 2Pirinitramide 2Morphine 2Laparoscopy 2Folfox protocol 2Capecitabine 2Bevacizumab 2Aspirin 2lanreotide 1Trastuzumab 1Taxes 1Standard of Care 1Sorafenib 1Sevoflurane 1Radiotherapy 1Radiofrequency Ablation 1Oxaliplatin 1Octreotide 1Neoadjuvant Therapy 1Magnetic Resonance Imaging 1Leucovorin 1Injections, Epidural 1Hematologic Tests 1Gemcitabine 1Everolimus 1Ethiodized Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Cells, Circulating × lanreotide × Gastrointestinal × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡